bs-60082C
[Life Science]
SCR7 --- NHEJ inhibitor
DATASHEET
Formulation Powder
Storage: Powder: 4C for 1 year.
Product Information:
Molecular Weight: 334.39
Formula: C18 H14 N4 O S
CAS Number: 1533426-72-0
InChi Key: NEEVCWPRIZJJRJ-AYKLPDECSA-N
InChi: InChI=1S/C18H14N4OS/c23-17-15(19-11-13-7-3-1-4-8-13)16(21-18(24)22-17)20-12-14-9-5-2-6-10-14/h1-12H,(H2,21,22,23,24)/b19-11+,20-12+
Smiles: OC1=NC(S)=NC(N=CC2C=CC=CC=2)=C1N=CC1C=CC=CC=1 |t:7,18|
Purity: 98.0
Solubility: DMSO up to 50 mM
Appearance: Solid Power
Shelf Life: 1.0 years
Formula: C18 H14 N4 O S
CAS Number: 1533426-72-0
InChi Key: NEEVCWPRIZJJRJ-AYKLPDECSA-N
InChi: InChI=1S/C18H14N4OS/c23-17-15(19-11-13-7-3-1-4-8-13)16(21-18(24)22-17)20-12-14-9-5-2-6-10-14/h1-12H,(H2,21,22,23,24)/b19-11+,20-12+
Smiles: OC1=NC(S)=NC(N=CC2C=CC=CC=2)=C1N=CC1C=CC=CC=1 |t:7,18|
Purity: 98.0
Solubility: DMSO up to 50 mM
Appearance: Solid Power
Shelf Life: 1.0 years
Description:
SCR7 is a potent and selective inhibitor of non-homologous end joining (NHEJ). It inhibits joining of DSBs in cell-free DNA repair system, blocks Ligase IV-mediated joining by interfering with its DNA binding but not that of T4 DNA Ligase or Ligase I, thereby leading to accumulation of DSBs within the cells, culminating into cytotoxicity. SCR7 inhibits NHEJ in a Ligase IV-dependent manner within cells, and activates the intrinsic apoptotic pathway. More importantly, SCR7 impedes tumor progression in mouse models, and when co-administered with DSB-inducing therapeutic modalities it enhances their sensitivity significantly. In addition, SCR7 can promote the efficiency of HDR 4–5-fold for CRISPR editing in both human and mouse cell lines.
Size: 2 mg solid, 10mg solid, 10 mM DMSO (0.598 mL2 mg solid, 10mg solid, 10 mM DMSO (0.598 mL)
Applications: Life Science()
For research use only. Not intended for diagnostic or therapeutic use.